Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
Conditions
- Pleural Effusion, Malignant
- Ascites, Malignant
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Renal Cell
- Carcinoma, Renal
- Carcinoma, Small Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Pancreatic Ductal
- Carcinoma, Neuroendocrine
- Carcinoma, Thymic
- Carcinoma, Pancreatic
- Carcinoma Breast
- Carcinoma, Ovarian
- Carcinoma Bladder
- Carcinoma of Unknown Primary
- Carcinoma of the Head and Neck
- Carcinoma of the Oropharynx
- Carcinoma of the Larynx
- Carcinoma of the Bladder
- Carcinoma of Esophagus
- Carcinoma of the Nasopharynx
- Carcinoma of the Penis
- Carcinoma of the Cervix
- Carcinoma of the Anus
- Carcinoma of the Vulva
- Carcinoma of the Appendix
- Carcinoma of the Oral Cavity
- Cholangiocarcinoma
- Melanoma
- Mesothelioma
- Pancreatic Cancer
Sponsor
Travera Inc
Collaborators